| Launch Year: | 2015 |
| Historical Start Date: | Drug Expiry: 1995; Review Designations: 1984 |
| Data Coverage: | Drug Expiry: 8,083 Drugs; Review Designations: 5,076 |
| Regional Coverage: | Europe/Middle East/Africa; Asia Pacific; North America |
| Country Coverage: | Drug Expiry: 3 (US, Europe & Japan); Review Designations: 5 (US, Europe, United Kingdom, China & Japan) |
| Company Coverage: | Drug Expiry: 3,312; Review Designations: 2,717 |
| Total Companies with Tickers: | Drug Expiry: 1,090; Review Designations: 830 |
| Collection Time: | Daily |
| Delivery Methods: | API, Cloud |
Pharma: Regulatory Milestones Tracker
GlobalData’s Regulatory Milestones Tracker provides a comprehensive and analytical view of constraining patent/drug expiry for marketed & pipeline drugs in the US, Europe, Japan, and China. Our database provides insight into regulatory designations such as Orphan Drug status, several Accelerated Approval Pathways, exclusivity data, and GlobalData also tracks Prescription Drug User Fee Act (PDUFA) date and Para IV filings, ensuring competitive analysis of entire landscape.
We track over 60,000+ sources as part of our curated secondary research program.
Data Characteristics
Still looking?
There’s more to discover. Gain direct access to our trusted data with over 150 raw datasets at your fingertips.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward